Total assets expanded about 56% to $192.1B entirely on the liability side while equity held near $26.6B, driving equity-to-assets down from 0.22 to 0.14 and leaving just $2.2B of cash plus $131.0M of investment securities against $165.5B of liabilities.
CME Group Inc. (CME) balance sheet — 26-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 |
|---|
| Cash & Short Term Investments | 11.66B | 4.54B | 3.01B | 3.02B | 2.82B | 2.95B | 1.73B | 1.63B | 1.45B | 1.99B | 1.95B | 1.77B | 1.44B | 2.54B | 1.66B | 10.42B | 4.94B | 6.29B | 607.97M | 1.05B | 3.87B | 3.66B | 747.51M | 812.17M | 3.15B | 1.9B | 30.66M |
| Cash & Due from Banks | 2.2B | 4.42B | 2.89B | 2.91B | 2.72B | 2.83B | 1.63B | 1.55B | 1.37B | 1.9B | 1.87B | 1.69B | 1.37B | 2.47B | 1.6B | 1.04B | 855.2M | 260.6M | 297.89M | 845.31M | 969.5M | 610.89M | 357.56M | 185.12M | 339.26M | 69.1M | 30.66M |
| Short Term Investments | 131M | 125M | 113.2M | 111.7M | 96M | 115M | 100.9M | 83.2M | 72.9M | 90.1M | 83.3M | 72.5M | 74.7M | 68.4M | 56.6M | 9.38B | 4.09B | 6.02B | 310.08M | 203.31M | 2.9B | 3.05B | 389.95M | 627.04M | 2.81B | 1.83B | 0 |
| Total Investments | 131M | 125M | 113.2M | 111.7M | 96M | 115M | 100.9M | 83.2M | 72.9M | 90.1M | 83.3M | 72.5M | 74.7M | 68.4M | 56.6M | 47.6M | 4.09B | 6.02B | 310.1M | 203.31M | 2.9B | 3.05B | 389.95M | 627.04M | 2.81B | 1.83B | 0 |
| Investments Growth % | 37.53% | 10.42% | 1.34% | 16.35% | -16.52% | 13.97% | 21.27% | 14.13% | -19.09% | 8.16% | 14.9% | -2.95% | 9.21% | 20.85% | 18.91% | -98.84% | -32.13% | 1842.76% | 52.53% | -92.99% | -4.72% | 681.1% | -37.81% | -77.71% | 53.8% | - | - |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivables | 788.1M | 639.2M | 573.1M | 535.6M | 483.2M | 434.5M | 461.3M | 491.8M | 553.3M | 359.7M | 364.4M | 357.8M | 341.2M | 302.7M | 267.5M | 289.4M | 297.5M | 248.3M | 234M | 187.49M | 121.13M | 86.98M | 78.83M | 52.97M | 50.87M | 40.99M | 28.53M |
| Goodwill & Intangibles | 30.12B | 30.3B | 30.48B | 30.72B | 30.93B | 31.24B | 32.84B | 33.04B | 33.48B | 27.09B | 27.19B | 27.28B | 27.38B | 27.49B | 27.6B | 28.34B | 28.48B | 27.78B | 27.87B | 14.83B | 24.27M | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 10.51B | 10.51B | 10.49B | 10.5B | 10.48B | 10.53B | 10.8B | 10.74B | 10.81B | 7.57B | 7.57B | 7.57B | 7.57B | 7.57B | 7.57B | 7.98B | 7.98B | 7.55B | 7.52B | 5.05B | 11.5M | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 19.62B | 19.79B | 20B | 20.23B | 20.45B | 20.71B | 22.04B | 22.29B | 22.68B | 19.52B | 19.62B | 19.71B | 19.81B | 19.92B | 20.03B | 20.35B | 20.49B | 20.23B | 20.35B | 9.78B | 12.78M | 0 | 0 | 0 | 0 | 0 | 0 |
| PP&E (Net) | 338.7M | 362.7M | 386.2M | 409.5M | 455.5M | 505.3M | 579.2M | 544M | 448.7M | 399.7M | 425.2M | 491.7M | 508.9M | 513.4M | 724M | 821.9M | 786.8M | 738.5M | 707.2M | 377.45M | 168.75M | 153.33M | 131.36M | 118.2M | 109.56M | 100.99M | 80.39M |
| Other Assets | 2.49B | 2.4B | 3.54B | 3.69B | 3.71B | 3.28B | 1.96B | 2.07B | 1.66B | 1.39B | 1.73B | 1.68B | 1.81B | 1.87B | 1.83B | 653.7M | 394.4M | 435.8M | 469.4M | 108.69M | 52.28M | 32.64M | 31.24M | 31.05M | 30.32M | 19.78M | 33.62M |
| Total Current Assets | 159.14B | 165.36B | 103.03B | 94.89B | 139.08B | 161.76B | 89.28B | 39.57B | 41.89B | 46.91B | 40.03B | 37.9B | 42.55B | 24.41B | 8.72B | 10.95B | 5.39B | 6.7B | 19.11B | 4.99B | 4.03B | 3.78B | 2.69B | 4.72B | 3.22B | 1.95B | 267.43M |
| Total Non-Current Assets | 32.95B | 33.06B | 34.41B | 34.82B | 35.1B | 35.02B | 35.38B | 35.65B | 35.59B | 28.88B | 29.34B | 29.45B | 29.7B | 29.87B | 30.15B | 29.81B | 29.66B | 28.95B | 29.05B | 15.32B | 276.25M | 185.97M | 162.6M | 149.26M | 139.88M | 120.77M | 114.01M |
| Total Assets | 192.09B | 198.42B | 137.45B | 129.71B | 174.18B | 196.78B | 124.66B | 75.22B | 77.48B | 75.79B | 69.37B | 67.36B | 72.24B | 54.28B | 38.86B | 40.76B | 35.05B | 35.65B | 48.16B | 20.31B | 4.31B | 3.97B | 2.86B | 4.87B | 3.36B | 2.07B | 381.44M |
| Asset Growth % | 83.2% | 44.36% | 5.97% | -25.53% | -11.49% | 57.85% | 65.74% | -2.92% | 2.22% | 9.26% | 2.98% | -6.76% | 33.1% | 39.66% | -4.65% | 16.3% | -1.7% | -25.97% | 137.16% | 371.52% | 8.49% | 38.91% | -41.36% | 45.23% | 62.32% | 441.86% | - |
| Return on Assets (ROA) | 2.24% | 2.41% | 2.64% | 2.12% | 1.45% | 1.64% | 2.11% | 2.77% | 2.56% | 5.6% | 2.24% | 1.79% | 1.78% | 2.1% | 2.25% | 4.78% | 2.69% | 1.97% | 2.09% | 5.35% | 9.84% | 8.99% | 5.68% | 2.97% | 3.47% | 5.58% | -1.55% |
| Accounts Payable | 67.7M | 71.8M | 79.9M | 90.6M | 121.4M | 48.8M | 69.3M | 61.9M | 116M | 31.3M | 26.2M | 28.7M | 36.9M | 36.2M | 41.7M | 31.1M | 51.8M | 46.7M | 71M | 58.97M | 25.55M | 23.55M | 23.05M | 24.69M | 27.61M | 23.83M | 11.9M |
| Total Debt | 3.43B | 3.42B | 3.43B | 3.43B | 3.44B | 3.45B | 3.44B | 3.74B | 4.4B | 46.42B | 39.77B | 37.78B | 42.67B | 2.86B | 2.86B | 11.44B | 2.53B | 2.31B | 3.22B | 164.44M | 521.18M | 0 | 0 | 1.51M | 2.33M | 6.65M | 6.06M |
| Net Debt | 1.23B | -994.6M | 535.6M | 513.4M | 718.3M | 610.2M | 1.81B | 2.19B | 3.03B | 44.51B | 37.91B | 36.09B | 41.31B | 387.4M | 1.25B | 10.4B | 1.67B | 2.05B | 2.92B | -680.88M | -448.32M | -610.89M | -357.56M | -183.61M | -336.93M | -62.45M | -24.59M |
| Long-Term Debt | 3.43B | 3.42B | 2.68B | 3.43B | 3.42B | 2.7B | 3.44B | 3.74B | 3.83B | 2.23B | 2.23B | 2.23B | 2.11B | 2.11B | 2.11B | 2.11B | 2.1B | 2.01B | 2.97B | 0 | 0 | 0 | 0 | 0 | 2.33M | 6.65M | 6.06M |
| Short-Term Debt | 0 | 0 | 749.8M | 0 | 16M | 749.4M | 0 | 0 | 574.2M | 44.19B | 37.54B | 35.55B | 40.57B | 749.9M | 749.7M | 9.33B | 420.5M | 299.8M | 249.9M | 164.44M | 521.18M | 0 | 0 | 1.51M | 0 | 0 | 0 |
| Other Liabilities | 785.6M | 734.8M | 721.2M | 798.2M | 826M | 896.5M | 1.06B | 1.16B | 745.1M | 615.7M | 560.9M | 395.5M | 376.2M | 449.4M | 220.5M | 187.6M | 191.5M | 165.8M | 132.7M | 76.26M | 32.06M | 20.78M | 19.25M | 21.67M | 17.05M | 10.02M | 13.42M |
| Total Current Liabilities | 156.11B | 160.3B | 102.31B | 93.42B | 137.69B | 160.4B | 88.2B | 38.52B | 41.27B | 45.67B | 38.95B | 36.82B | 41.53B | 23.31B | 7.62B | 9.62B | 4.78B | 6.52B | 18.64B | 4.08B | 2.76B | 2.83B | 2.03B | 4.29B | 2.89B | 1.8B | 198.29M |
| Total Non-Current Liabilities | 9.42B | 9.4B | 8.65B | 9.55B | 9.61B | 8.98B | 10.11B | 10.53B | 10.24B | 7.71B | 10.08B | 9.98B | 9.79B | 9.81B | 9.74B | 9.52B | 10.14B | 9.83B | 10.83B | 3.92B | 32.06M | 20.78M | 19.25M | 21.67M | 19.38M | 16.67M | 19.48M |
| Total Liabilities | 165.53B | 169.7B | 110.96B | 102.97B | 147.3B | 169.38B | 98.31B | 49.06B | 51.51B | 53.38B | 49.03B | 46.81B | 51.32B | 33.12B | 17.36B | 19.14B | 14.92B | 16.35B | 29.47B | 8B | 2.79B | 2.85B | 2.04B | 4.31B | 2.91B | 1.82B | 217.77M |
| Total Equity | 26.56B | 28.73B | 26.49B | 26.74B | 26.88B | 27.4B | 26.35B | 26.16B | 25.97B | 22.41B | 20.34B | 20.55B | 20.92B | 21.16B | 21.51B | 21.62B | 20.13B | 19.3B | 18.69B | 12.31B | 1.52B | 1.12B | 812.6M | 563M | 446.14M | 248.37M | 163.67M |
| Equity Growth % | -3.24% | 8.46% | -0.94% | -0.52% | -1.9% | 3.98% | 0.73% | 0.75% | 15.86% | 10.18% | -1.03% | -1.78% | -1.12% | -1.61% | -0.54% | 7.42% | 4.29% | 3.28% | 51.87% | 710.07% | 35.79% | 37.67% | 44.33% | 26.19% | 79.63% | 51.75% | - |
| Equity / Assets (Capital Ratio) | 13.83% | 14.48% | 19.27% | 20.61% | 15.43% | 13.92% | 21.14% | 34.78% | 33.51% | 29.57% | 29.32% | 30.51% | 28.96% | 38.99% | 55.34% | 53.05% | 57.43% | 54.14% | 38.81% | 60.6% | 35.27% | 28.18% | 28.44% | 11.55% | 13.3% | 12.02% | 42.91% |
| Return on Equity (ROE) | 16.24% | 14.65% | 13.25% | 12.03% | 9.92% | 9.81% | 8.02% | 8.12% | 8.11% | 19.01% | 7.5% | 6.01% | 5.36% | 4.58% | 4.16% | 8.68% | 4.83% | 4.35% | 4.62% | 9.53% | 30.89% | 31.78% | 31.92% | 24.21% | 27.09% | 33.15% | -3.61% |
| Book Value per Share | 74.06 | 79.75 | 73.59 | 74.38 | 74.83 | 76.34 | 73.50 | 73.02 | 75.54 | 65.87 | 60.01 | 60.82 | 62.26 | 63.28 | 64.71 | 64.77 | 60.54 | 58.01 | 63.39 | 55.80 | 8.65 | 6.42 | 4.72 | 3.32 | 2.97 | 1.70 | 1.14 |
| Tangible BV per Share | -9.93 | -4.37 | -11.10 | -11.08 | -11.27 | -10.69 | -18.10 | -19.19 | -21.86 | -13.75 | -20.19 | -19.92 | -19.22 | -18.91 | -18.33 | -20.12 | -25.11 | -25.48 | -31.14 | -11.46 | 8.51 | 6.42 | 4.72 | 3.32 | 2.97 | 1.70 | 1.14 |
| Common Stock | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.4M | 3.4M | 3.4M | 3.4M | 3.3M | 3.3M | 3.3M | 700K | 700K | 700K | 533K | 348K | 345K | 341K | 329K | 325K | 288K | 288K |
| Additional Paid-in Capital | 0 | 22.21B | 22.4B | 22.33B | 22.26B | 22.19B | 21.19B | 21.11B | 21.05B | 17.9B | 17.83B | 17.72B | 17.6B | 17.5B | 17.21B | 17.11B | 17.28B | 17.19B | 17.13B | 10.69B | 405.51M | 324.85M | 261.05M | 195.22M | 179.67M | 59.23M | 43.88M |
| Retained Earnings | 6.03B | 6.43B | 4.19B | 4.46B | 4.75B | 5.15B | 5B | 5.01B | 4.86B | 4.5B | 2.52B | 2.91B | 3.32B | 3.49B | 3.99B | 4.32B | 2.89B | 2.24B | 1.72B | 1.62B | 1.12B | 796.4M | 552.8M | 368.31M | 266.81M | 190.03M | 119.51M |
| Accumulated OCI | 55.5M | 81.9M | -105.5M | -55.6M | -133.3M | 53.5M | 134.9M | 3.4M | 5.3M | 14.3M | -14.1M | -80.8M | 6.2M | 152M | 209.3M | 111.6M | -104.1M | -126.2M | -160.3M | -3.1M | -2.98M | -2.91M | -1.59M | -868K | -665K | -1.18M | -11K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CME stock.
As of 2025, CME Group Inc. (CME) had total assets of $198.42B including $165.36B in current assets.
CME Group Inc. (CME) carries total debt of $3.42B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
CME Group Inc. (CME) has total shareholders' equity (book value) of $28.73B ($79.75 book value per share). Book value represents the net worth of the company belonging to common stock holders.
CME Group Inc. (CME) reported a current ratio of 1.03x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Counterparty exposure outpacing capital
Metrics are mathematically derived from official filings.
Asset Growth Liability-Driven
According to CME's reported balance sheet, total assets expanded roughly 56% over ten quarters, from $123.4B in 2024Q2 to $192.1B in 2026Q3, while equity was essentially flat at $26.6B, meaning the entire expansion sits on the liability side rather than in invested assets.
This is not balance sheet expansion in the industrial sense; the growth appears attributable to accumulated clearing member performance bonds and deposits, which are custodial in nature and move with margin requirements rather than with lending activity. Investors should avoid reading the $69B asset increase as balance sheet deepening — it reflects CME's growing clearing franchise and collateral throughput, which explains why the equity base was permitted to stay flat while ROE drifted between 3.2% and 4.2%.
Collateral Replaces Deposit Franchise
The funding franchise is dominated by clearing member collateral rather than retail or corporate deposits: total liabilities of $165.5B in 2026Q3 far outstrip the $2.2B of cash and bank balances held, and net interest income has swung from -$44.0M to $1.4B across eight quarters, per CME's quarterly disclosures.
CME's funding stability derives from the stickiness of margin posted against open futures positions, not from insured or relationship deposits, so the liability base should be read as a volatility-linked float rather than a classic deposit franchise. The NII discontinuity suggests interest earned on client collateral has become a material and rate-sensitive earnings component, which may indicate that funding economics are increasingly hostage to where policy rates settle rather than to CME's own pricing power.
Provision Spike Flags Clearing Risk
CME carries no traditional loan book — the loan-to-deposit field is blank throughout — yet provision for credit losses spiked to $568.3M in 2026Q2, more than triple the $165M-$197M quarterly range of 2024-2025, before falling to $60.7M in Q3, as disclosed in CME's financial statements.
With no loans outstanding, this line can only be interpreted as clearing member, default fund, or guarantee-related credit assessment, and the magnitude of the Q2 charge against record volumes suggests an episodic event rather than gradual portfolio deterioration. The pattern is consistent with a recalibration of counterparty risk reserves, but the data provided do not identify the driver, so analysts should treat the subsequent normalization to $60.7M cautiously rather than as resolution.
Capital Flat as Assets Inflate
Equity has hovered near $26.5-$28.7B for ten quarters, but the equity-to-assets ratio has compressed from 0.22 to 0.14 not through capital erosion — the asset base simply grew faster; according to CME's reported figures, ROE of 3.9% in 2026Q3 sits below the 4.2% printed in 2026Q1.
The capital cushion itself appears intact in absolute terms, and prior cash flow findings showing a $2.7B variable dividend in 2026Q1 and $698.2M of buybacks in Q2 confirm management is distributing surplus rather than retaining it. The declining ratio is therefore an optics artifact of collateral accumulation, but it does mean each dollar of capital now stands behind a larger pool of default-related obligations, warranting closer scrutiny of capital relative to clearing exposure than relative to assets.
Thin Securities Buffer by Design
Liquid assets are strikingly thin relative to the balance sheet: $2.2B of cash and bank balances and just $131.0M of investment securities against $192.1B of total assets in 2026Q3, implying liquidity rests on collateral mobility rather than portfolio holdings, based on CME's reported balance sheet.
The near-absence of a securities book — with the sole exception of $1.6B in 2025Q4 — indicates CME deliberately avoids duration and unrealized-loss exposure, keeping its treasury function minimal and its balance sheet free of the AOCI drag that burdens rate-sensitive peers. This is a structurally conservative posture, though it also means the provided data reveal no meaningful contingent liquidity buffer; committed facility capacity is not disclosed here and warrants further investigation.
Growth May Mask Rising Exposure
The most under-appreciated risk is that CME's balance sheet growth may signal rising counterparty exposure rather than strength: assets grew 56% while provisions reached $568.3M and equity stayed flat, a combination suggesting default-related claims could be accumulating faster than capital, per CME's quarterly data.
Analysts typically treat a 56% asset increase as expansion, but for a clearinghouse whose assets are largely claims arising from member defaults and collateral, the more relevant question is whether the obligations backing that growth are matched by capital that has not moved in ten quarters. Read alongside the volatile NII line and the Q2 provision surge, this suggests the balance sheet's apparent fortress quality may be understating the sensitivity of CME's capital to a severe clearing member stress event.